Encompassing a group of complex and heterogeneous diseases, cancer continues to be a
challenge for patients and healthcare systems worldwide. Thus, it is of vital importance to …

Urologic cancers (UC) account for 13.1% of all new cancer cases and 7.9% of all cancer-
related deaths. A growing body of evidence has indicated a potential causal link between …

Background Although sex bias has been reported in the development and progression of
renal cell carcinoma (RCC), the underlying mechanisms remain enigmatic. Here, we …

Background Understanding the past and future burden of kidney cancer in China over years
provides essential references for optimizing the prevention and management strategies …

N6-Methyladenosine (m6A) is the most abundant posttranscriptional modification, and its
contribution to cancer evolution has recently been appreciated. Renal cancer is the most …

Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer, affecting
hundreds of thousands of people worldwide and can affect people of any age. The …

Background Clear cell renal cell carcinoma (ccRCC) displays sex-biased incidence,
outcomes, molecular alterations and treatment efficacy; however, clinical managements are …

Multiple studies have demonstrated the importance of androgen receptor (AR) splice
variants (SVs) in the progression of prostate cancer to the castration-resistant phenotype …

Kidney cancer (KC) is a disease with a rising worldwide incidence estimated at 400 000 new
cases annually, and a worldwide mortality rate approaching 175 000 deaths per year …

Objectives To identify the clinical risk factors that influence in-hospital mortality in elderly
patients with persistent sepsis-associated acute kidney injury (S-AKI) and to establish and …